More than six months ago, New Cannabis Ventures warned of pending changes in Canada with respect to medical cannabis reimbursement for Veterans. The Veterans Affairs Canada expenditures have skyrocketed since the ACMPR program (previously known as MMPR) began in 2014, with a large quantity (10 grams per day) and high price limit ($14 per gram) allowing up to $4200 a month expenditure per veteran.

Today, Vice News has reported that a change is imminent by May 2017.  Further, it named several companies that may be responsible for potential abuses of the system, including Aphria (TSXV: APH) (OTC: APHQF), Marijuana For Trauma, which recently was acquired by a Canada House Wellness (TSXV: CHV) (OTC: SARSF), which was previously Abba Medix, and MedReleaf, which is privately held.

Read Justin Ling’s “High Prices: The cost of medical marijuana benefits for vets has jumped 5000% in Canada.”: https://news.vice.com/story/veteran-medical-marijuana-benefits-are-costing-canada-a-fortune

Published by NCV Newswire

The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.